Indegene (NSE:INDGN) Short Interest


NSE:INDGN Indegene Ltd NSE:INDGN
49 GF Score
Price ₹513.75
! 5 Warning Signs
View Full Analysis

What is Indegene Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:INDGN vs VEEV, BTSG, TEM: Short Interest Comparison

For the Health Information Services subindustry, Indegene's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indegene Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indegene's Short Interest distribution charts can be found below:

* The bar in red indicates where Indegene's Short Interest falls into.


NSE:INDGN
49GF Score
Indegene Ltd NSE:INDGN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indegene Business Description

Other Exchanges 544172:India
Address Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score

Get the complete analysis for NSE:INDGN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹513.75
Price